Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, rad (Q33614786)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, rad |
scientific article |
Statements
1 reference
Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, rad (English)
1 reference
Jun Hashimoto
1 reference
Patrick Garnero
1 reference
Nobuyuki Miyasaka
1 reference
Kazuhiko Yamamoto
1 reference
Shinichi Kawai
1 reference
Tsutomu Takeuchi
1 reference
Hideki Yoshikawa
1 reference
Norihiro Nishimoto
1 reference
24 June 2010
1 reference
1 reference
21
1 reference
10-15
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference